A recent study highlighted that GDF11 treatment reduced both mRNA and protein levels of GFAP and Iba1 in a mouse model of Alzheimer’s disease, suggesting a role of GDF11 in attenuation of neuroinflammation [15]. This evidence concerns the gene GFAP and early-onset autosomal dominant Alzheimer disease.